Global Long-acting Melatonin Receptor Agonists Market Growth (Status and Outlook) 2026-2032
The global Long-acting Melatonin Receptor Agonists market size is predicted to grow from US$ 452 million in 2025 to US$ 702 million in 2032; it is expected to grow at a CAGR of 6.4% from 2026 to 2032.
Long-acting melatonin receptor agonists are prescription medicines containing melatonin and formulated with prolonged-release, extended-release, or controlled-release technologies to extend overnight drug release and MT1 and MT2 receptor activity. Commercial products mainly include 2 mg prolonged-release tablets for adults and 1 mg or 5 mg prolonged-release minitablets for pediatric patients. Major indications include primary insomnia and insomnia associated with autism spectrum disorder, Smith-Magenis syndrome, other neurogenetic disorders, and selected pediatric attention-deficit hyperactivity disorder populations. Upstream inputs mainly include pharmaceutical-grade melatonin, modified-release matrix materials, methacrylate copolymers, cellulose derivatives, fillers, coating materials, blister packs, and pharmaceutical bottles. Downstream customers mainly include sleep medicine centers, psychiatric departments, pediatric departments, neurodevelopmental disorder clinics, hospital pharmacies, retail pharmacies, and specialty pharmacies. The market is centered on prescription prolonged-release formulations. Originator pediatric products retain relatively high added value, while adult 2 mg prolonged-release tablets face increasing generic competition, with an overall gross margin generally ranging from approximately 48% to 72%.
From the current market perspective, the long-acting melatonin receptor agonist market consists mainly of adult 2 mg prolonged-release melatonin products and pediatric prolonged-release formulations. The adult segment is concentrated in primary insomnia among older patients and includes both originator and generic products. Pediatric products primarily address insomnia associated with autism spectrum disorder, neurogenetic diseases, and other neurodevelopmental disorders. These populations are smaller but require more specialized diagnosis and treatment, supporting higher unit values for branded pediatric formulations.
Looking ahead, development will increasingly focus on pediatric dosage forms, minitablets, easy-to-swallow formulations, and more consistent overnight release profiles. Manufacturers will optimize release rates, overnight exposure, morning residual effects, and dosing for different age and weight groups. Generic penetration will continue to increase in the adult 2 mg segment, while pediatric products will rely more heavily on proprietary formulations, indication expansion, and specialist promotion.
Key market drivers include population aging, increasing recognition of sleep disorders, improved diagnosis of pediatric neurodevelopmental conditions, and greater physician acceptance of non-GABAergic insomnia treatments. These products are generally not controlled substances and have lower abuse and physical-dependence risks than benzodiazepines and Z-drugs, making them suitable for patients requiring longer treatment or unable to tolerate conventional sedative-hypnotics. Expansion into autism, ADHD, and neurogenetic disorder-related insomnia will create additional prescription demand.
The main constraints include relatively modest clinical efficacy in some patients and variable improvement in sleep onset and maintenance. Low-priced and widely available over-the-counter immediate-release melatonin products create substantial substitution pressure. Regulatory classification of melatonin as a medicine, food, or dietary supplement differs by country, resulting in inconsistent reimbursement, prescribing, and market-access conditions. Generic competition and reimbursement controls will also continue to reduce average selling prices in the adult segment.
LPI (LP Information)' newest research report, the “Long-acting Melatonin Receptor Agonists Industry Forecast” looks at past sales and reviews total world Long-acting Melatonin Receptor Agonists sales in 2025, providing a comprehensive analysis by region and market sector of projected Long-acting Melatonin Receptor Agonists sales for 2026 through 2032. With Long-acting Melatonin Receptor Agonists sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-acting Melatonin Receptor Agonists industry.
This Insight Report provides a comprehensive analysis of the global Long-acting Melatonin Receptor Agonists landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Long-acting Melatonin Receptor Agonists portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long-acting Melatonin Receptor Agonists market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-acting Melatonin Receptor Agonists and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-acting Melatonin Receptor Agonists.
This report presents a comprehensive overview, market shares, and growth opportunities of Long-acting Melatonin Receptor Agonists market by product type, application, key players and key regions and countries.
Long-acting melatonin receptor agonists are prescription medicines containing melatonin and formulated with prolonged-release, extended-release, or controlled-release technologies to extend overnight drug release and MT1 and MT2 receptor activity. Commercial products mainly include 2 mg prolonged-release tablets for adults and 1 mg or 5 mg prolonged-release minitablets for pediatric patients. Major indications include primary insomnia and insomnia associated with autism spectrum disorder, Smith-Magenis syndrome, other neurogenetic disorders, and selected pediatric attention-deficit hyperactivity disorder populations. Upstream inputs mainly include pharmaceutical-grade melatonin, modified-release matrix materials, methacrylate copolymers, cellulose derivatives, fillers, coating materials, blister packs, and pharmaceutical bottles. Downstream customers mainly include sleep medicine centers, psychiatric departments, pediatric departments, neurodevelopmental disorder clinics, hospital pharmacies, retail pharmacies, and specialty pharmacies. The market is centered on prescription prolonged-release formulations. Originator pediatric products retain relatively high added value, while adult 2 mg prolonged-release tablets face increasing generic competition, with an overall gross margin generally ranging from approximately 48% to 72%.
From the current market perspective, the long-acting melatonin receptor agonist market consists mainly of adult 2 mg prolonged-release melatonin products and pediatric prolonged-release formulations. The adult segment is concentrated in primary insomnia among older patients and includes both originator and generic products. Pediatric products primarily address insomnia associated with autism spectrum disorder, neurogenetic diseases, and other neurodevelopmental disorders. These populations are smaller but require more specialized diagnosis and treatment, supporting higher unit values for branded pediatric formulations.
Looking ahead, development will increasingly focus on pediatric dosage forms, minitablets, easy-to-swallow formulations, and more consistent overnight release profiles. Manufacturers will optimize release rates, overnight exposure, morning residual effects, and dosing for different age and weight groups. Generic penetration will continue to increase in the adult 2 mg segment, while pediatric products will rely more heavily on proprietary formulations, indication expansion, and specialist promotion.
Key market drivers include population aging, increasing recognition of sleep disorders, improved diagnosis of pediatric neurodevelopmental conditions, and greater physician acceptance of non-GABAergic insomnia treatments. These products are generally not controlled substances and have lower abuse and physical-dependence risks than benzodiazepines and Z-drugs, making them suitable for patients requiring longer treatment or unable to tolerate conventional sedative-hypnotics. Expansion into autism, ADHD, and neurogenetic disorder-related insomnia will create additional prescription demand.
The main constraints include relatively modest clinical efficacy in some patients and variable improvement in sleep onset and maintenance. Low-priced and widely available over-the-counter immediate-release melatonin products create substantial substitution pressure. Regulatory classification of melatonin as a medicine, food, or dietary supplement differs by country, resulting in inconsistent reimbursement, prescribing, and market-access conditions. Generic competition and reimbursement controls will also continue to reduce average selling prices in the adult segment.
LPI (LP Information)' newest research report, the “Long-acting Melatonin Receptor Agonists Industry Forecast” looks at past sales and reviews total world Long-acting Melatonin Receptor Agonists sales in 2025, providing a comprehensive analysis by region and market sector of projected Long-acting Melatonin Receptor Agonists sales for 2026 through 2032. With Long-acting Melatonin Receptor Agonists sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-acting Melatonin Receptor Agonists industry.
This Insight Report provides a comprehensive analysis of the global Long-acting Melatonin Receptor Agonists landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Long-acting Melatonin Receptor Agonists portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long-acting Melatonin Receptor Agonists market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-acting Melatonin Receptor Agonists and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-acting Melatonin Receptor Agonists.
This report presents a comprehensive overview, market shares, and growth opportunities of Long-acting Melatonin Receptor Agonists market by product type, application, key players and key regions and countries.
Segmentation by Type:
- 1 mg
- 2 mg
- 5 mg
- Other
Segmentation by Product Status:
- Originator Drug
- Generic Drugs
Segmentation by Release Profile:
- Prolonged-release
- Extended-release
- Modified-release
Segmentation by Application:
- Hospital
- Clinic
- Other
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Neurim Pharmaceuticals
- Flynn Pharma
- Viatris
- Teva Pharmaceutical Industries
- Aurobindo Pharma
- Sandoz
- Zentiva
- Neuraxpharm
- Wockhardt
- Medice
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-acting Melatonin Receptor Agonists Market Size (2021-2032)
2.1.2 Long-acting Melatonin Receptor Agonists Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Long-acting Melatonin Receptor Agonists by Country/Region (2021, 2025 & 2032)
2.2 Long-acting Melatonin Receptor Agonists Segment by Type
2.2.1 1 mg
2.2.2 2 mg
2.2.3 5 mg
2.2.4 Other
2.2.5 Long-acting Melatonin Receptor Agonists Market Size by Type
2.2.5.1 Long-acting Melatonin Receptor Agonists Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Type (2021-2026)
2.3 Long-acting Melatonin Receptor Agonists Segment by Product Status
2.3.1 Originator Drug
2.3.2 Generic Drugs
2.3.3 Long-acting Melatonin Receptor Agonists Market Size by Product Status
2.3.3.1 Long-acting Melatonin Receptor Agonists Market Size CAGR by Product Status (2021 VS 2025 VS 2032)
2.3.3.2 Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Product Status (2021-2026)
2.4 Long-acting Melatonin Receptor Agonists Segment by Release Profile
2.4.1 Prolonged-release
2.4.2 Extended-release
2.4.3 Modified-release
2.4.4 Long-acting Melatonin Receptor Agonists Market Size by Release Profile
2.4.4.1 Long-acting Melatonin Receptor Agonists Market Size CAGR by Release Profile (2021 VS 2025 VS 2032)
2.4.4.2 Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Release Profile (2021-2026)
2.5 Long-acting Melatonin Receptor Agonists Segment by Application
2.5.1 Hospital
2.5.2 Clinic
2.5.3 Other
2.5.4 Long-acting Melatonin Receptor Agonists Market Size by Application
2.5.4.1 Long-acting Melatonin Receptor Agonists Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Application (2021-2026)
3 LONG-ACTING MELATONIN RECEPTOR AGONISTS MARKET SIZE BY PLAYER
3.1 Long-acting Melatonin Receptor Agonists Market Size Market Share by Player
3.1.1 Global Long-acting Melatonin Receptor Agonists Revenue by Player (2021-2026)
3.1.2 Global Long-acting Melatonin Receptor Agonists Revenue Market Share by Player (2021-2026)
3.2 Global Long-acting Melatonin Receptor Agonists Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LONG-ACTING MELATONIN RECEPTOR AGONISTS BY REGION
4.1 Long-acting Melatonin Receptor Agonists Market Size by Region (2021-2026)
4.2 Global Long-acting Melatonin Receptor Agonists Annual Revenue by Country/Region (2021-2026)
4.3 Americas Long-acting Melatonin Receptor Agonists Market Size Growth (2021-2026)
4.4 APAC Long-acting Melatonin Receptor Agonists Market Size Growth (2021-2026)
4.5 Europe Long-acting Melatonin Receptor Agonists Market Size Growth (2021-2026)
4.6 Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026)
5.2 Americas Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026)
5.3 Americas Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-acting Melatonin Receptor Agonists Market Size by Region (2021-2026)
6.2 APAC Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026)
6.3 APAC Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026)
7.2 Europe Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026)
7.3 Europe Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-acting Melatonin Receptor Agonists by Region (2021-2026)
8.2 Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026)
8.3 Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LONG-ACTING MELATONIN RECEPTOR AGONISTS MARKET FORECAST
10.1 Global Long-acting Melatonin Receptor Agonists Forecast by Region (2027-2032)
10.1.1 Global Long-acting Melatonin Receptor Agonists Forecast by Region (2027-2032)
10.1.2 Americas Long-acting Melatonin Receptor Agonists Forecast
10.1.3 APAC Long-acting Melatonin Receptor Agonists Forecast
10.1.4 Europe Long-acting Melatonin Receptor Agonists Forecast
10.1.5 Middle East & Africa Long-acting Melatonin Receptor Agonists Forecast
10.2 Americas Long-acting Melatonin Receptor Agonists Forecast by Country (2027-2032)
10.2.1 United States Market Long-acting Melatonin Receptor Agonists Forecast
10.2.2 Canada Market Long-acting Melatonin Receptor Agonists Forecast
10.2.3 Mexico Market Long-acting Melatonin Receptor Agonists Forecast
10.2.4 Brazil Market Long-acting Melatonin Receptor Agonists Forecast
10.3 APAC Long-acting Melatonin Receptor Agonists Forecast by Region (2027-2032)
10.3.1 China Long-acting Melatonin Receptor Agonists Market Forecast
10.3.2 Japan Market Long-acting Melatonin Receptor Agonists Forecast
10.3.3 Korea Market Long-acting Melatonin Receptor Agonists Forecast
10.3.4 Southeast Asia Market Long-acting Melatonin Receptor Agonists Forecast
10.3.5 India Market Long-acting Melatonin Receptor Agonists Forecast
10.3.6 Australia Market Long-acting Melatonin Receptor Agonists Forecast
10.4 Europe Long-acting Melatonin Receptor Agonists Forecast by Country (2027-2032)
10.4.1 Germany Market Long-acting Melatonin Receptor Agonists Forecast
10.4.2 France Market Long-acting Melatonin Receptor Agonists Forecast
10.4.3 UK Market Long-acting Melatonin Receptor Agonists Forecast
10.4.4 Italy Market Long-acting Melatonin Receptor Agonists Forecast
10.4.5 Russia Market Long-acting Melatonin Receptor Agonists Forecast
10.5 Middle East & Africa Long-acting Melatonin Receptor Agonists Forecast by Region (2027-2032)
10.5.1 Egypt Market Long-acting Melatonin Receptor Agonists Forecast
10.5.2 South Africa Market Long-acting Melatonin Receptor Agonists Forecast
10.5.3 Israel Market Long-acting Melatonin Receptor Agonists Forecast
10.5.4 Turkey Market Long-acting Melatonin Receptor Agonists Forecast
10.6 Global Long-acting Melatonin Receptor Agonists Forecast by Type (2027-2032)
10.7 Global Long-acting Melatonin Receptor Agonists Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Long-acting Melatonin Receptor Agonists Forecast
11 KEY PLAYERS ANALYSIS
11.1 Neurim Pharmaceuticals
11.1.1 Neurim Pharmaceuticals Company Information
11.1.2 Neurim Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Offered
11.1.3 Neurim Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Neurim Pharmaceuticals Main Business Overview
11.1.5 Neurim Pharmaceuticals Latest Developments
11.2 Flynn Pharma
11.2.1 Flynn Pharma Company Information
11.2.2 Flynn Pharma Long-acting Melatonin Receptor Agonists Product Offered
11.2.3 Flynn Pharma Long-acting Melatonin Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Flynn Pharma Main Business Overview
11.2.5 Flynn Pharma Latest Developments
11.3 Viatris
11.3.1 Viatris Company Information
11.3.2 Viatris Long-acting Melatonin Receptor Agonists Product Offered
11.3.3 Viatris Long-acting Melatonin Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Viatris Main Business Overview
11.3.5 Viatris Latest Developments
11.4 Teva Pharmaceutical Industries
11.4.1 Teva Pharmaceutical Industries Company Information
11.4.2 Teva Pharmaceutical Industries Long-acting Melatonin Receptor Agonists Product Offered
11.4.3 Teva Pharmaceutical Industries Long-acting Melatonin Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Teva Pharmaceutical Industries Main Business Overview
11.4.5 Teva Pharmaceutical Industries Latest Developments
11.5 Aurobindo Pharma
11.5.1 Aurobindo Pharma Company Information
11.5.2 Aurobindo Pharma Long-acting Melatonin Receptor Agonists Product Offered
11.5.3 Aurobindo Pharma Long-acting Melatonin Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Aurobindo Pharma Main Business Overview
11.5.5 Aurobindo Pharma Latest Developments
11.6 Sandoz
11.6.1 Sandoz Company Information
11.6.2 Sandoz Long-acting Melatonin Receptor Agonists Product Offered
11.6.3 Sandoz Long-acting Melatonin Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Sandoz Main Business Overview
11.6.5 Sandoz Latest Developments
11.7 Zentiva
11.7.1 Zentiva Company Information
11.7.2 Zentiva Long-acting Melatonin Receptor Agonists Product Offered
11.7.3 Zentiva Long-acting Melatonin Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Zentiva Main Business Overview
11.7.5 Zentiva Latest Developments
11.8 Neuraxpharm
11.8.1 Neuraxpharm Company Information
11.8.2 Neuraxpharm Long-acting Melatonin Receptor Agonists Product Offered
11.8.3 Neuraxpharm Long-acting Melatonin Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Neuraxpharm Main Business Overview
11.8.5 Neuraxpharm Latest Developments
11.9 Wockhardt
11.9.1 Wockhardt Company Information
11.9.2 Wockhardt Long-acting Melatonin Receptor Agonists Product Offered
11.9.3 Wockhardt Long-acting Melatonin Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Wockhardt Main Business Overview
11.9.5 Wockhardt Latest Developments
11.10 Medice
11.10.1 Medice Company Information
11.10.2 Medice Long-acting Melatonin Receptor Agonists Product Offered
11.10.3 Medice Long-acting Melatonin Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Medice Main Business Overview
11.10.5 Medice Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-acting Melatonin Receptor Agonists Market Size (2021-2032)
2.1.2 Long-acting Melatonin Receptor Agonists Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Long-acting Melatonin Receptor Agonists by Country/Region (2021, 2025 & 2032)
2.2 Long-acting Melatonin Receptor Agonists Segment by Type
2.2.1 1 mg
2.2.2 2 mg
2.2.3 5 mg
2.2.4 Other
2.2.5 Long-acting Melatonin Receptor Agonists Market Size by Type
2.2.5.1 Long-acting Melatonin Receptor Agonists Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Type (2021-2026)
2.3 Long-acting Melatonin Receptor Agonists Segment by Product Status
2.3.1 Originator Drug
2.3.2 Generic Drugs
2.3.3 Long-acting Melatonin Receptor Agonists Market Size by Product Status
2.3.3.1 Long-acting Melatonin Receptor Agonists Market Size CAGR by Product Status (2021 VS 2025 VS 2032)
2.3.3.2 Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Product Status (2021-2026)
2.4 Long-acting Melatonin Receptor Agonists Segment by Release Profile
2.4.1 Prolonged-release
2.4.2 Extended-release
2.4.3 Modified-release
2.4.4 Long-acting Melatonin Receptor Agonists Market Size by Release Profile
2.4.4.1 Long-acting Melatonin Receptor Agonists Market Size CAGR by Release Profile (2021 VS 2025 VS 2032)
2.4.4.2 Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Release Profile (2021-2026)
2.5 Long-acting Melatonin Receptor Agonists Segment by Application
2.5.1 Hospital
2.5.2 Clinic
2.5.3 Other
2.5.4 Long-acting Melatonin Receptor Agonists Market Size by Application
2.5.4.1 Long-acting Melatonin Receptor Agonists Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Application (2021-2026)
3 LONG-ACTING MELATONIN RECEPTOR AGONISTS MARKET SIZE BY PLAYER
3.1 Long-acting Melatonin Receptor Agonists Market Size Market Share by Player
3.1.1 Global Long-acting Melatonin Receptor Agonists Revenue by Player (2021-2026)
3.1.2 Global Long-acting Melatonin Receptor Agonists Revenue Market Share by Player (2021-2026)
3.2 Global Long-acting Melatonin Receptor Agonists Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LONG-ACTING MELATONIN RECEPTOR AGONISTS BY REGION
4.1 Long-acting Melatonin Receptor Agonists Market Size by Region (2021-2026)
4.2 Global Long-acting Melatonin Receptor Agonists Annual Revenue by Country/Region (2021-2026)
4.3 Americas Long-acting Melatonin Receptor Agonists Market Size Growth (2021-2026)
4.4 APAC Long-acting Melatonin Receptor Agonists Market Size Growth (2021-2026)
4.5 Europe Long-acting Melatonin Receptor Agonists Market Size Growth (2021-2026)
4.6 Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026)
5.2 Americas Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026)
5.3 Americas Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-acting Melatonin Receptor Agonists Market Size by Region (2021-2026)
6.2 APAC Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026)
6.3 APAC Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026)
7.2 Europe Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026)
7.3 Europe Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-acting Melatonin Receptor Agonists by Region (2021-2026)
8.2 Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026)
8.3 Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LONG-ACTING MELATONIN RECEPTOR AGONISTS MARKET FORECAST
10.1 Global Long-acting Melatonin Receptor Agonists Forecast by Region (2027-2032)
10.1.1 Global Long-acting Melatonin Receptor Agonists Forecast by Region (2027-2032)
10.1.2 Americas Long-acting Melatonin Receptor Agonists Forecast
10.1.3 APAC Long-acting Melatonin Receptor Agonists Forecast
10.1.4 Europe Long-acting Melatonin Receptor Agonists Forecast
10.1.5 Middle East & Africa Long-acting Melatonin Receptor Agonists Forecast
10.2 Americas Long-acting Melatonin Receptor Agonists Forecast by Country (2027-2032)
10.2.1 United States Market Long-acting Melatonin Receptor Agonists Forecast
10.2.2 Canada Market Long-acting Melatonin Receptor Agonists Forecast
10.2.3 Mexico Market Long-acting Melatonin Receptor Agonists Forecast
10.2.4 Brazil Market Long-acting Melatonin Receptor Agonists Forecast
10.3 APAC Long-acting Melatonin Receptor Agonists Forecast by Region (2027-2032)
10.3.1 China Long-acting Melatonin Receptor Agonists Market Forecast
10.3.2 Japan Market Long-acting Melatonin Receptor Agonists Forecast
10.3.3 Korea Market Long-acting Melatonin Receptor Agonists Forecast
10.3.4 Southeast Asia Market Long-acting Melatonin Receptor Agonists Forecast
10.3.5 India Market Long-acting Melatonin Receptor Agonists Forecast
10.3.6 Australia Market Long-acting Melatonin Receptor Agonists Forecast
10.4 Europe Long-acting Melatonin Receptor Agonists Forecast by Country (2027-2032)
10.4.1 Germany Market Long-acting Melatonin Receptor Agonists Forecast
10.4.2 France Market Long-acting Melatonin Receptor Agonists Forecast
10.4.3 UK Market Long-acting Melatonin Receptor Agonists Forecast
10.4.4 Italy Market Long-acting Melatonin Receptor Agonists Forecast
10.4.5 Russia Market Long-acting Melatonin Receptor Agonists Forecast
10.5 Middle East & Africa Long-acting Melatonin Receptor Agonists Forecast by Region (2027-2032)
10.5.1 Egypt Market Long-acting Melatonin Receptor Agonists Forecast
10.5.2 South Africa Market Long-acting Melatonin Receptor Agonists Forecast
10.5.3 Israel Market Long-acting Melatonin Receptor Agonists Forecast
10.5.4 Turkey Market Long-acting Melatonin Receptor Agonists Forecast
10.6 Global Long-acting Melatonin Receptor Agonists Forecast by Type (2027-2032)
10.7 Global Long-acting Melatonin Receptor Agonists Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Long-acting Melatonin Receptor Agonists Forecast
11 KEY PLAYERS ANALYSIS
11.1 Neurim Pharmaceuticals
11.1.1 Neurim Pharmaceuticals Company Information
11.1.2 Neurim Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Offered
11.1.3 Neurim Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Neurim Pharmaceuticals Main Business Overview
11.1.5 Neurim Pharmaceuticals Latest Developments
11.2 Flynn Pharma
11.2.1 Flynn Pharma Company Information
11.2.2 Flynn Pharma Long-acting Melatonin Receptor Agonists Product Offered
11.2.3 Flynn Pharma Long-acting Melatonin Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Flynn Pharma Main Business Overview
11.2.5 Flynn Pharma Latest Developments
11.3 Viatris
11.3.1 Viatris Company Information
11.3.2 Viatris Long-acting Melatonin Receptor Agonists Product Offered
11.3.3 Viatris Long-acting Melatonin Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Viatris Main Business Overview
11.3.5 Viatris Latest Developments
11.4 Teva Pharmaceutical Industries
11.4.1 Teva Pharmaceutical Industries Company Information
11.4.2 Teva Pharmaceutical Industries Long-acting Melatonin Receptor Agonists Product Offered
11.4.3 Teva Pharmaceutical Industries Long-acting Melatonin Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Teva Pharmaceutical Industries Main Business Overview
11.4.5 Teva Pharmaceutical Industries Latest Developments
11.5 Aurobindo Pharma
11.5.1 Aurobindo Pharma Company Information
11.5.2 Aurobindo Pharma Long-acting Melatonin Receptor Agonists Product Offered
11.5.3 Aurobindo Pharma Long-acting Melatonin Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Aurobindo Pharma Main Business Overview
11.5.5 Aurobindo Pharma Latest Developments
11.6 Sandoz
11.6.1 Sandoz Company Information
11.6.2 Sandoz Long-acting Melatonin Receptor Agonists Product Offered
11.6.3 Sandoz Long-acting Melatonin Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Sandoz Main Business Overview
11.6.5 Sandoz Latest Developments
11.7 Zentiva
11.7.1 Zentiva Company Information
11.7.2 Zentiva Long-acting Melatonin Receptor Agonists Product Offered
11.7.3 Zentiva Long-acting Melatonin Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Zentiva Main Business Overview
11.7.5 Zentiva Latest Developments
11.8 Neuraxpharm
11.8.1 Neuraxpharm Company Information
11.8.2 Neuraxpharm Long-acting Melatonin Receptor Agonists Product Offered
11.8.3 Neuraxpharm Long-acting Melatonin Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Neuraxpharm Main Business Overview
11.8.5 Neuraxpharm Latest Developments
11.9 Wockhardt
11.9.1 Wockhardt Company Information
11.9.2 Wockhardt Long-acting Melatonin Receptor Agonists Product Offered
11.9.3 Wockhardt Long-acting Melatonin Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Wockhardt Main Business Overview
11.9.5 Wockhardt Latest Developments
11.10 Medice
11.10.1 Medice Company Information
11.10.2 Medice Long-acting Melatonin Receptor Agonists Product Offered
11.10.3 Medice Long-acting Melatonin Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Medice Main Business Overview
11.10.5 Medice Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Long-acting Melatonin Receptor Agonists Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Long-acting Melatonin Receptor Agonists Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 1 mg
Table 4. Major Players of 2 mg
Table 5. Major Players of 5 mg
Table 6. Major Players of Other
Table 7. Long-acting Melatonin Receptor Agonists Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Originator Drug
Table 11. Major Players of Generic Drugs
Table 12. Long-acting Melatonin Receptor Agonists Market Size CAGR by Product Status (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Long-acting Melatonin Receptor Agonists Market Size by Product Status (2021-2026) & ($ millions)
Table 14. Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Product Status (2021-2026)
Table 15. Major Players of Prolonged-release
Table 16. Major Players of Extended-release
Table 17. Major Players of Modified-release
Table 18. Long-acting Melatonin Receptor Agonists Market Size CAGR by Release Profile (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Long-acting Melatonin Receptor Agonists Market Size by Release Profile (2021-2026) & ($ millions)
Table 20. Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Release Profile (2021-2026)
Table 21. Long-acting Melatonin Receptor Agonists Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026) & ($ millions)
Table 23. Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Application (2021-2026)
Table 24. Global Long-acting Melatonin Receptor Agonists Revenue by Player (2021-2026) & ($ millions)
Table 25. Global Long-acting Melatonin Receptor Agonists Revenue Market Share by Player (2021-2026)
Table 26. Long-acting Melatonin Receptor Agonists Key Players Head office and Products Offered
Table 27. Long-acting Melatonin Receptor Agonists Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Long-acting Melatonin Receptor Agonists Market Size by Region (2021-2026) & ($ millions)
Table 31. Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Region (2021-2026)
Table 32. Global Long-acting Melatonin Receptor Agonists Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Long-acting Melatonin Receptor Agonists Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas Long-acting Melatonin Receptor Agonists Market Size Market Share by Country (2021-2026)
Table 36. Americas Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas Long-acting Melatonin Receptor Agonists Market Size Market Share by Type (2021-2026)
Table 38. Americas Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas Long-acting Melatonin Receptor Agonists Market Size Market Share by Application (2021-2026)
Table 40. APAC Long-acting Melatonin Receptor Agonists Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC Long-acting Melatonin Receptor Agonists Market Size Market Share by Region (2021-2026)
Table 42. APAC Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe Long-acting Melatonin Receptor Agonists Market Size Market Share by Country (2021-2026)
Table 46. Europe Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of Long-acting Melatonin Receptor Agonists
Table 52. Key Market Challenges & Risks of Long-acting Melatonin Receptor Agonists
Table 53. Key Industry Trends of Long-acting Melatonin Receptor Agonists
Table 54. Global Long-acting Melatonin Receptor Agonists Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global Long-acting Melatonin Receptor Agonists Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global Long-acting Melatonin Receptor Agonists Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global Long-acting Melatonin Receptor Agonists Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. Neurim Pharmaceuticals Details, Company Type, Long-acting Melatonin Receptor Agonists Area Served and Its Competitors
Table 59. Neurim Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Offered
Table 60. Neurim Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Neurim Pharmaceuticals Main Business
Table 62. Neurim Pharmaceuticals Latest Developments
Table 63. Flynn Pharma Details, Company Type, Long-acting Melatonin Receptor Agonists Area Served and Its Competitors
Table 64. Flynn Pharma Long-acting Melatonin Receptor Agonists Product Offered
Table 65. Flynn Pharma Long-acting Melatonin Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Flynn Pharma Main Business
Table 67. Flynn Pharma Latest Developments
Table 68. Viatris Details, Company Type, Long-acting Melatonin Receptor Agonists Area Served and Its Competitors
Table 69. Viatris Long-acting Melatonin Receptor Agonists Product Offered
Table 70. Viatris Long-acting Melatonin Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Viatris Main Business
Table 72. Viatris Latest Developments
Table 73. Teva Pharmaceutical Industries Details, Company Type, Long-acting Melatonin Receptor Agonists Area Served and Its Competitors
Table 74. Teva Pharmaceutical Industries Long-acting Melatonin Receptor Agonists Product Offered
Table 75. Teva Pharmaceutical Industries Long-acting Melatonin Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Teva Pharmaceutical Industries Main Business
Table 77. Teva Pharmaceutical Industries Latest Developments
Table 78. Aurobindo Pharma Details, Company Type, Long-acting Melatonin Receptor Agonists Area Served and Its Competitors
Table 79. Aurobindo Pharma Long-acting Melatonin Receptor Agonists Product Offered
Table 80. Aurobindo Pharma Long-acting Melatonin Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Aurobindo Pharma Main Business
Table 82. Aurobindo Pharma Latest Developments
Table 83. Sandoz Details, Company Type, Long-acting Melatonin Receptor Agonists Area Served and Its Competitors
Table 84. Sandoz Long-acting Melatonin Receptor Agonists Product Offered
Table 85. Sandoz Long-acting Melatonin Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Sandoz Main Business
Table 87. Sandoz Latest Developments
Table 88. Zentiva Details, Company Type, Long-acting Melatonin Receptor Agonists Area Served and Its Competitors
Table 89. Zentiva Long-acting Melatonin Receptor Agonists Product Offered
Table 90. Zentiva Long-acting Melatonin Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Zentiva Main Business
Table 92. Zentiva Latest Developments
Table 93. Neuraxpharm Details, Company Type, Long-acting Melatonin Receptor Agonists Area Served and Its Competitors
Table 94. Neuraxpharm Long-acting Melatonin Receptor Agonists Product Offered
Table 95. Neuraxpharm Long-acting Melatonin Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Neuraxpharm Main Business
Table 97. Neuraxpharm Latest Developments
Table 98. Wockhardt Details, Company Type, Long-acting Melatonin Receptor Agonists Area Served and Its Competitors
Table 99. Wockhardt Long-acting Melatonin Receptor Agonists Product Offered
Table 100. Wockhardt Long-acting Melatonin Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Wockhardt Main Business
Table 102. Wockhardt Latest Developments
Table 103. Medice Details, Company Type, Long-acting Melatonin Receptor Agonists Area Served and Its Competitors
Table 104. Medice Long-acting Melatonin Receptor Agonists Product Offered
Table 105. Medice Long-acting Melatonin Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Medice Main Business
Table 107. Medice Latest Developments
Table 1. Long-acting Melatonin Receptor Agonists Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Long-acting Melatonin Receptor Agonists Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 1 mg
Table 4. Major Players of 2 mg
Table 5. Major Players of 5 mg
Table 6. Major Players of Other
Table 7. Long-acting Melatonin Receptor Agonists Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Originator Drug
Table 11. Major Players of Generic Drugs
Table 12. Long-acting Melatonin Receptor Agonists Market Size CAGR by Product Status (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Long-acting Melatonin Receptor Agonists Market Size by Product Status (2021-2026) & ($ millions)
Table 14. Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Product Status (2021-2026)
Table 15. Major Players of Prolonged-release
Table 16. Major Players of Extended-release
Table 17. Major Players of Modified-release
Table 18. Long-acting Melatonin Receptor Agonists Market Size CAGR by Release Profile (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Long-acting Melatonin Receptor Agonists Market Size by Release Profile (2021-2026) & ($ millions)
Table 20. Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Release Profile (2021-2026)
Table 21. Long-acting Melatonin Receptor Agonists Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026) & ($ millions)
Table 23. Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Application (2021-2026)
Table 24. Global Long-acting Melatonin Receptor Agonists Revenue by Player (2021-2026) & ($ millions)
Table 25. Global Long-acting Melatonin Receptor Agonists Revenue Market Share by Player (2021-2026)
Table 26. Long-acting Melatonin Receptor Agonists Key Players Head office and Products Offered
Table 27. Long-acting Melatonin Receptor Agonists Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Long-acting Melatonin Receptor Agonists Market Size by Region (2021-2026) & ($ millions)
Table 31. Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Region (2021-2026)
Table 32. Global Long-acting Melatonin Receptor Agonists Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Long-acting Melatonin Receptor Agonists Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas Long-acting Melatonin Receptor Agonists Market Size Market Share by Country (2021-2026)
Table 36. Americas Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas Long-acting Melatonin Receptor Agonists Market Size Market Share by Type (2021-2026)
Table 38. Americas Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas Long-acting Melatonin Receptor Agonists Market Size Market Share by Application (2021-2026)
Table 40. APAC Long-acting Melatonin Receptor Agonists Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC Long-acting Melatonin Receptor Agonists Market Size Market Share by Region (2021-2026)
Table 42. APAC Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe Long-acting Melatonin Receptor Agonists Market Size Market Share by Country (2021-2026)
Table 46. Europe Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of Long-acting Melatonin Receptor Agonists
Table 52. Key Market Challenges & Risks of Long-acting Melatonin Receptor Agonists
Table 53. Key Industry Trends of Long-acting Melatonin Receptor Agonists
Table 54. Global Long-acting Melatonin Receptor Agonists Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global Long-acting Melatonin Receptor Agonists Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global Long-acting Melatonin Receptor Agonists Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global Long-acting Melatonin Receptor Agonists Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. Neurim Pharmaceuticals Details, Company Type, Long-acting Melatonin Receptor Agonists Area Served and Its Competitors
Table 59. Neurim Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Offered
Table 60. Neurim Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Neurim Pharmaceuticals Main Business
Table 62. Neurim Pharmaceuticals Latest Developments
Table 63. Flynn Pharma Details, Company Type, Long-acting Melatonin Receptor Agonists Area Served and Its Competitors
Table 64. Flynn Pharma Long-acting Melatonin Receptor Agonists Product Offered
Table 65. Flynn Pharma Long-acting Melatonin Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Flynn Pharma Main Business
Table 67. Flynn Pharma Latest Developments
Table 68. Viatris Details, Company Type, Long-acting Melatonin Receptor Agonists Area Served and Its Competitors
Table 69. Viatris Long-acting Melatonin Receptor Agonists Product Offered
Table 70. Viatris Long-acting Melatonin Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Viatris Main Business
Table 72. Viatris Latest Developments
Table 73. Teva Pharmaceutical Industries Details, Company Type, Long-acting Melatonin Receptor Agonists Area Served and Its Competitors
Table 74. Teva Pharmaceutical Industries Long-acting Melatonin Receptor Agonists Product Offered
Table 75. Teva Pharmaceutical Industries Long-acting Melatonin Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Teva Pharmaceutical Industries Main Business
Table 77. Teva Pharmaceutical Industries Latest Developments
Table 78. Aurobindo Pharma Details, Company Type, Long-acting Melatonin Receptor Agonists Area Served and Its Competitors
Table 79. Aurobindo Pharma Long-acting Melatonin Receptor Agonists Product Offered
Table 80. Aurobindo Pharma Long-acting Melatonin Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Aurobindo Pharma Main Business
Table 82. Aurobindo Pharma Latest Developments
Table 83. Sandoz Details, Company Type, Long-acting Melatonin Receptor Agonists Area Served and Its Competitors
Table 84. Sandoz Long-acting Melatonin Receptor Agonists Product Offered
Table 85. Sandoz Long-acting Melatonin Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Sandoz Main Business
Table 87. Sandoz Latest Developments
Table 88. Zentiva Details, Company Type, Long-acting Melatonin Receptor Agonists Area Served and Its Competitors
Table 89. Zentiva Long-acting Melatonin Receptor Agonists Product Offered
Table 90. Zentiva Long-acting Melatonin Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Zentiva Main Business
Table 92. Zentiva Latest Developments
Table 93. Neuraxpharm Details, Company Type, Long-acting Melatonin Receptor Agonists Area Served and Its Competitors
Table 94. Neuraxpharm Long-acting Melatonin Receptor Agonists Product Offered
Table 95. Neuraxpharm Long-acting Melatonin Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Neuraxpharm Main Business
Table 97. Neuraxpharm Latest Developments
Table 98. Wockhardt Details, Company Type, Long-acting Melatonin Receptor Agonists Area Served and Its Competitors
Table 99. Wockhardt Long-acting Melatonin Receptor Agonists Product Offered
Table 100. Wockhardt Long-acting Melatonin Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Wockhardt Main Business
Table 102. Wockhardt Latest Developments
Table 103. Medice Details, Company Type, Long-acting Melatonin Receptor Agonists Area Served and Its Competitors
Table 104. Medice Long-acting Melatonin Receptor Agonists Product Offered
Table 105. Medice Long-acting Melatonin Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Medice Main Business
Table 107. Medice Latest Developments
LIST OF FIGURES
Figure 1. Long-acting Melatonin Receptor Agonists Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Long-acting Melatonin Receptor Agonists Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Long-acting Melatonin Receptor Agonists Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Long-acting Melatonin Receptor Agonists Sales Market Share by Country/Region (2025)
Figure 8. Long-acting Melatonin Receptor Agonists Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Type in 2025
Figure 10. Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Product Status in 2025
Figure 11. Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Release Profile in 2025
Figure 12. Long-acting Melatonin Receptor Agonists in Hospital
Figure 13. Global Long-acting Melatonin Receptor Agonists Market: Hospital (2021-2026) & ($ millions)
Figure 14. Long-acting Melatonin Receptor Agonists in Clinic
Figure 15. Global Long-acting Melatonin Receptor Agonists Market: Clinic (2021-2026) & ($ millions)
Figure 16. Long-acting Melatonin Receptor Agonists in Other
Figure 17. Global Long-acting Melatonin Receptor Agonists Market: Other (2021-2026) & ($ millions)
Figure 18. Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Application in 2025
Figure 19. Global Long-acting Melatonin Receptor Agonists Revenue Market Share by Player in 2025
Figure 20. Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Region (2021-2026)
Figure 21. Americas Long-acting Melatonin Receptor Agonists Market Size 2021-2026 ($ millions)
Figure 22. APAC Long-acting Melatonin Receptor Agonists Market Size 2021-2026 ($ millions)
Figure 23. Europe Long-acting Melatonin Receptor Agonists Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size 2021-2026 ($ millions)
Figure 25. Americas Long-acting Melatonin Receptor Agonists Value Market Share by Country in 2025
Figure 26. United States Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Long-acting Melatonin Receptor Agonists Market Size Market Share by Region in 2025
Figure 31. APAC Long-acting Melatonin Receptor Agonists Market Size Market Share by Type (2021-2026)
Figure 32. APAC Long-acting Melatonin Receptor Agonists Market Size Market Share by Application (2021-2026)
Figure 33. China Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 37. India Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Long-acting Melatonin Receptor Agonists Market Size Market Share by Country in 2025
Figure 40. Europe Long-acting Melatonin Receptor Agonists Market Size Market Share by Type (2021-2026)
Figure 41. Europe Long-acting Melatonin Receptor Agonists Market Size Market Share by Application (2021-2026)
Figure 42. Germany Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 43. France Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 56. APAC Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 57. Europe Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 59. United States Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 60. Canada Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 61. Mexico Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 62. Brazil Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 63. China Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 64. Japan Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 65. Korea Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 67. India Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 68. Australia Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 69. Germany Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 70. France Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 71. UK Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 72. Italy Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 73. Russia Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 74. Egypt Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 75. South Africa Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 76. Israel Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 77. Turkey Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 78. Global Long-acting Melatonin Receptor Agonists Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Long-acting Melatonin Receptor Agonists Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 1. Long-acting Melatonin Receptor Agonists Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Long-acting Melatonin Receptor Agonists Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Long-acting Melatonin Receptor Agonists Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Long-acting Melatonin Receptor Agonists Sales Market Share by Country/Region (2025)
Figure 8. Long-acting Melatonin Receptor Agonists Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Type in 2025
Figure 10. Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Product Status in 2025
Figure 11. Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Release Profile in 2025
Figure 12. Long-acting Melatonin Receptor Agonists in Hospital
Figure 13. Global Long-acting Melatonin Receptor Agonists Market: Hospital (2021-2026) & ($ millions)
Figure 14. Long-acting Melatonin Receptor Agonists in Clinic
Figure 15. Global Long-acting Melatonin Receptor Agonists Market: Clinic (2021-2026) & ($ millions)
Figure 16. Long-acting Melatonin Receptor Agonists in Other
Figure 17. Global Long-acting Melatonin Receptor Agonists Market: Other (2021-2026) & ($ millions)
Figure 18. Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Application in 2025
Figure 19. Global Long-acting Melatonin Receptor Agonists Revenue Market Share by Player in 2025
Figure 20. Global Long-acting Melatonin Receptor Agonists Market Size Market Share by Region (2021-2026)
Figure 21. Americas Long-acting Melatonin Receptor Agonists Market Size 2021-2026 ($ millions)
Figure 22. APAC Long-acting Melatonin Receptor Agonists Market Size 2021-2026 ($ millions)
Figure 23. Europe Long-acting Melatonin Receptor Agonists Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size 2021-2026 ($ millions)
Figure 25. Americas Long-acting Melatonin Receptor Agonists Value Market Share by Country in 2025
Figure 26. United States Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Long-acting Melatonin Receptor Agonists Market Size Market Share by Region in 2025
Figure 31. APAC Long-acting Melatonin Receptor Agonists Market Size Market Share by Type (2021-2026)
Figure 32. APAC Long-acting Melatonin Receptor Agonists Market Size Market Share by Application (2021-2026)
Figure 33. China Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 37. India Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Long-acting Melatonin Receptor Agonists Market Size Market Share by Country in 2025
Figure 40. Europe Long-acting Melatonin Receptor Agonists Market Size Market Share by Type (2021-2026)
Figure 41. Europe Long-acting Melatonin Receptor Agonists Market Size Market Share by Application (2021-2026)
Figure 42. Germany Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 43. France Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Long-acting Melatonin Receptor Agonists Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 56. APAC Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 57. Europe Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 59. United States Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 60. Canada Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 61. Mexico Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 62. Brazil Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 63. China Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 64. Japan Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 65. Korea Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 67. India Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 68. Australia Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 69. Germany Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 70. France Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 71. UK Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 72. Italy Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 73. Russia Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 74. Egypt Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 75. South Africa Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 76. Israel Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 77. Turkey Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
Figure 78. Global Long-acting Melatonin Receptor Agonists Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Long-acting Melatonin Receptor Agonists Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Long-acting Melatonin Receptor Agonists Market Size 2027-2032 ($ millions)
